Argitalpenak (37) Ikertzaileren baten partaidetza izan duten argitalpenak

2024

  1. Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective study

    Neurology Perspectives, Vol. 4, Núm. 1

2022

  1. The real-world effectiveness and safety of perampanel in Europe: A scoping review

    Epilepsy and Behavior, Vol. 134

2021

  1. COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study

    Epilepsy and Behavior, Vol. 125

  2. Relationship between sleep quality and cognitive performance in patients with epilepsy

    Epilepsy and Behavior, Vol. 122

2020

  1. Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs

    Seizure, Vol. 83, pp. 48-56

2019

  1. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

  2. Description of stroke mimics after complete neurovascular assessment

    Neurologia, Vol. 34, Núm. 1, pp. 7-13

  3. Reactive Disruption of the Hippocampal Neurogenic Niche After Induction of Seizures by Injection of Kainic Acid in the Amygdala

    Frontiers in Cell and Developmental Biology, Vol. 7

2018

  1. Alcohol overuse and intracerebral hemorrhage: characteristics and long-term outcome

    European Journal of Neurology, Vol. 25, Núm. 11, pp. 1358-1364

  2. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry

    The Lancet Neurology, Vol. 17, Núm. 6, pp. 530-538

  3. Epilepsias

    Neurología (Elsevier), pp. 359-412

  4. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy

    Epilepsy and Behavior, Vol. 84, pp. 93-98

  5. Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data

    Epilepsia, Vol. 59, Núm. 9, pp. 1727-1739

  6. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

2017

  1. Cardiovascular autonomic and hemodynamic responses to vagus nerve stimulation in drug-resistant epilepsy

    Seizure, Vol. 45, pp. 56-60

  2. VNS and pregnancy: A multicentric experience of four cases

    Acta Neurologica Scandinavica

2016

  1. Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling

    PLoS Biology, Vol. 14, Núm. 5

  2. One-year clinical experience of perampanel in Spain: A multicentre study of efficacy and tolerability

    Epileptic Disorders, Vol. 18, Núm. 2, pp. 173-180

2015

  1. Vagus nerve stimulation therapy for treatment-resistant epilepsy: A 15-year experience at a single institution

    Clinical Neurology and Neurosurgery, Vol. 137, pp. 89-93

2012

  1. Laforin and malin deletions in mice produce similar neurologic impairments

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 5, pp. 413-421